Incyte in Netherlands
E-mail: hellobenelux@incyte.com
Web: https://incyte.nl/
Address:
-
Incyte Biosciences Benelux BV
Paasheuvelweg 25 1105 BP Amsterdam
Phone: +31 20 261 9300
Other Incyte's locations around the world
Clinical Trials sponsored by Incyte
-
Incyte Biosciences UK완전한가속기 만성 골수성 백혈병 | 만성기 만성 골수성 백혈병 | 필라델피아 염색체 양성 급성 림프구성 백혈병 | 모세포기 만성 골수성 백혈병영국, 아일랜드
-
Incyte Biosciences Japan GK모병미만성 거대 B세포 림프종 | 비호지킨 림프종일본
-
Incyte Biosciences International Sàrl완전한
-
Incyte Biosciences International Sàrl종료됨
-
Incyte Biosciences International Sàrl완전한자궁 경부암 | 간세포 암 | 식도암 | 난소 암 | 중피종 | 비소세포폐암(NSCLC) | 요로상피암 | 메르켈 세포 암종 | 미만성 거대 B세포 림프종 | 삼중 음성 유방암 | 신장 세포 암종(RCC) | 소세포 폐암(SCLC) | 머리와 목의 편평 세포 암종(SCCHN) | 현미부수체 불안정성(MSI)-높은 자궁내막암 | 위암(위와 위식도 접합부[GEJ] 포함) | 흑색종(포도막 흑색종 제외) | MSI-높은 대장암미국
-
Incyte Biosciences International Sàrl빼는BCR-ABL 양성 급성 림프구성 백혈병독일, 프랑스, 체코
-
Incyte Biosciences Benelux완전한만성 골수성 백혈병 | CML | 필라델피아 염색체 양성 급성 림프구성 백혈병 | Ph+ 모두벨기에
-
Incyte Corporation모병화농땀샘염(HS)미국, 오스트리아, 벨기에, 캐나다, 독일, 폴란드, 스페인, 호주, 덴마크, 프랑스, 영국, 일본, 불가리아, 네덜란드, 체코, 그리스, 이탈리아
-
Incyte Corporation모병비분절성 백반증독일, 미국, 이탈리아, 폴란드, 캐나다, 프랑스, 불가리아, 헝가리, 영국
About Incyte
Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. Our drug discovery and development efforts were founded in 2002 in Wilmington, Delaware, by a team of research scientists, chemists and biologists working in immunology. Today, we employ approximately 1500 people and have operations in the U.S., Europe and Japan. Our unique expertise in medicinal chemistry and biology have enabled us to create a diversified portfolio of marketed products and clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing pipeline of medicines across two franchises: Oncology and Inflammation & Autoimmunity. The commitment of our talented team of world-class scientists to continued scientific excellence has enabled us to identify new molecules, decipher new pathways and develop first-in-class and best-in-class medicines.